Natco Pharma Limited has informed the Exchange regarding a press release dated August 20, 2025, titled "NATCO launches Bosentan Tablets for Oral Suspension (generic of Tracleer®) in the United States with 180-day exclusivity".
Natco Pharma Limited has informed the Exchange regarding a press release dated August 20, 2025, titled "NATCO launches Bosentan Tablets for Oral Suspension (generic of Tracleer®) in the United States with 180-day exclusivity".